Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bromfenac 0.09% Versus Dexamethasone 0.1% Ophthalmic Solutions to Reduce Inflammation After Cataract Surgery

NCT03317847 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT03317847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03317847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bromfenac 0.09% Versus Dexamethasone 0.1% Ophthalmic Solutions to Reduce Inflammation After Cataract Surgery
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Phase 4
Overall status
Completed
Start date
October 16, 2017
Completion date
December 21, 2019
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation eye